189 related articles for article (PubMed ID: 27236861)
1. Prognostic value of preoperative von Willebrand factor plasma levels in patients with Glioblastoma.
Marfia G; Navone SE; Fanizzi C; Tabano S; Pesenti C; Abdel Hadi L; Franzini A; Caroli M; Miozzo M; Riboni L; Rampini P; Campanella R
Cancer Med; 2016 Aug; 5(8):1783-90. PubMed ID: 27236861
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Preoperative Von Willebrand Factor with Magnetic Resonance Imaging Perfusion and Permeability Parameters as Predictors of Prognosis in Glioblastoma.
Navone SE; Doniselli FM; Summers P; Guarnaccia L; Rampini P; Locatelli M; Campanella R; Marfia G; Costa A
World Neurosurg; 2019 Feb; 122():e226-e234. PubMed ID: 30312827
[TBL] [Abstract][Full Text] [Related]
3. Significance and Prognostic Value of The Coagulation Profile in Patients with Glioblastoma: Implications for Personalized Therapy.
Navone SE; Guarnaccia L; Locatelli M; Rampini P; Caroli M; La Verde N; Gaudino C; Bettinardi N; Riboni L; Marfia G; Campanella R
World Neurosurg; 2019 Jan; 121():e621-e629. PubMed ID: 30292037
[TBL] [Abstract][Full Text] [Related]
4. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma.
Gállego Pérez-Larraya J; Paris S; Idbaih A; Dehais C; Laigle-Donadey F; Navarro S; Capelle L; Mokhtari K; Marie Y; Sanson M; Hoang-Xuan K; Delattre JY; Mallet A
Cancer; 2014 Dec; 120(24):3972-80. PubMed ID: 25139333
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients.
Kefayat A; Amouheidari A; Ghahremani F; Alirezaei Z
Cancer Med; 2021 Aug; 10(15):5154-5162. PubMed ID: 34250760
[TBL] [Abstract][Full Text] [Related]
7. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
[TBL] [Abstract][Full Text] [Related]
8. A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen.
Stufano F; Lawrie AS; La Marca S; Berbenni C; Baronciani L; Peyvandi F
Haemophilia; 2014 Jan; 20(1):147-53. PubMed ID: 24028703
[TBL] [Abstract][Full Text] [Related]
9. von Willebrand Factor Antigen Predicts Outcomes in Patients after Liver Resection of Hepatocellular Carcinoma.
Schwarz C; Fitschek F; Mittlböck M; Saukel V; Bota S; Ferlitsch M; Ferlitsch A; Bodingbauer M; Kaczirek K
Gut Liver; 2020 Mar; 14(2):218-224. PubMed ID: 30428508
[TBL] [Abstract][Full Text] [Related]
10. Quantitative and qualitative assessment of plasma von Willebrand factor in classic Kaposi's sarcoma.
Hodak E; Trattner A; David M; Kornbrot N; Modan B; Lurie H; Lawrie A; Harrison P; Sandbank M; Inbal A
J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):217-21. PubMed ID: 8432918
[TBL] [Abstract][Full Text] [Related]
11. Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome.
Karsy M; Burnett B; Di Ieva A; Cusimano MD; Jensen RL
J Neurosurg; 2018 Mar; 128(3):657-666. PubMed ID: 28362240
[TBL] [Abstract][Full Text] [Related]
12. von Willebrand factor antigen levels in plasma of patients with malignant breast disease.
Röhsig LM; Damin DC; Stefani SD; Castro CG; Roisenberg I; Schwartsmann G
Braz J Med Biol Res; 2001 Sep; 34(9):1125-9. PubMed ID: 11514835
[TBL] [Abstract][Full Text] [Related]
13. Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study.
Sonneveld MA; Cheng JM; Oemrawsingh RM; de Maat MP; Kardys I; Garcia-Garcia HM; van Geuns RJ; Regar E; Serruys PW; Boersma E; Akkerhuis KM; Leebeek FW
Thromb Haemost; 2015 Mar; 113(3):577-84. PubMed ID: 25472874
[TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenstrom macroglobulinemia.
Hivert B; Caron C; Petit S; Charpy C; Fankam-Siaka C; Lecocq S; Zawadzki C; Susen S; Rusu M; Duhamel A; Tournilhac O; Goudemand J; Morel P
Blood; 2012 Oct; 120(16):3214-21. PubMed ID: 22896002
[TBL] [Abstract][Full Text] [Related]
15. Plasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinoma.
Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen PM
World J Gastroenterol; 2005 Apr; 11(14):2166-70. PubMed ID: 15810086
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of desmopressin (DDAVP) response in adult patients with type 1 von Willebrand disease.
Guddati AK; Rosovsky RP; Van Cott EM; Kuter DJ
Int J Lab Hematol; 2019 Jun; 41(3):325-330. PubMed ID: 30735311
[TBL] [Abstract][Full Text] [Related]
17. The effects of cardiopulmonary bypass on systemic and coronary levels of von Willebrand factor.
Holdright DR; Hunt BJ; Parratt R; Segal H; Clarke D; Taggart D; Bennett G; Collins P
Eur J Cardiothorac Surg; 1995; 9(1):18-21. PubMed ID: 7727141
[TBL] [Abstract][Full Text] [Related]
18. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes.
Tobin WO; Kinsella JA; Kavanagh GF; O'Donnell JS; McGrath RT; Tierney S; Egan B; Feeley TM; Coughlan T; Collins DR; O'Neill D; Murphy S; Lim SJ; Murphy RP; McCabe D
J Neurol Sci; 2017 Apr; 375():404-410. PubMed ID: 28320178
[TBL] [Abstract][Full Text] [Related]
19. Laboratory Testing for von Willebrand Factor Antigen (VWF:Ag).
Favaloro EJ; Mohammed S; Patzke J
Methods Mol Biol; 2017; 1646():403-416. PubMed ID: 28804844
[TBL] [Abstract][Full Text] [Related]
20. Circulating von Willebrand factor antigen as a predictor of short-term prognosis in pulmonary hypertension.
Lopes AA; Maeda NY
Chest; 1998 Nov; 114(5):1276-82. PubMed ID: 9824001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
